Miniaturization of an Osmotic Pressure-Based Glucose Sensor for Continuous Intraperitoneal and Subcutaneous Glucose Monitoring by Means of Nanotechnology
Sensors · 2023
DOI: 10.3390/s23094541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, 2023. Verfasst von Andreas Pfützner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lifecare AS, 5058 Bergen, Norway. Hauptthemen laut MEDLINE: Blood Glucose, Biosensing Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU Horizon 2020 Grant Program, Lifecare AS, Bergen, Norway, European Union’s Horizon 2020 research and innovation program.
Abstract (Originalsprache)
The Sencell sensor uses glucose-induced changes in an osmotic pressure chamber for continuous glucose measurement. A final device shall have the size of a grain of rice. The size limiting factor is the piezo-resistive pressure transducers inside the core sensor technology (resulting chamber volume: 70 µL. To achieve the necessary miniaturization, these pressure transducers were replaced by small (4000 × 400 × 150 nm³) nano-granular tunneling resistive (NTR) pressure sensors (chamber volume: 750 nL). For benchmark testing, we filled the miniaturized chamber with bovine serum albumin (BSA, 1 mM) and exposed it repeatedly to distilled water followed by 1 mM BSA solution. Thereafter, we manufactured sensors with glucose testing chemistry (ConcanavalinA/dextran) and investigated sensor performance with dynamic glucose changes between 0 and 300 mg/dL. Evaluation of the miniaturized sensors resulted in reliable pressure changes, both in the BSA benchmark experiment (30–35 mBar) and in the dynamic in vitro continuous glucose test (40–50 mBar). These pressure results were comparable to similar experiments with the previous larger in vitro sensors (30–50 mBar). In conclusion, the NTR pressure sensor technology was successfully employed to reduce the size of the core osmotic pressure chamber by more than 95% without loss in the osmotic pressure signal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lifecare AS, 5058 Bergen, Norway.
- Lifecare Nanobiosensors GmbH, 55128 Mainz, Germany.
- Lifecare Laboratories GmbH, 55128 Mainz, Germany.
- Pfützner Science & Health Institute, 55128 Mainz, Germany.
- Institute for Internal Medicine and Laboratory Medicine, University for Digital Technologies in Medicine & Dentistry, 9516 Wiltz, Luxembourg.
- Institute of Physics, Goethe-Universität, 60323 Frankfurt am Main, Germany.
ORCID-Profile: Andreas Pfützner, Michael Huth
Förderung
- EU Horizon 2020 Grant Program
- Lifecare AS, Bergen, Norway
- European Union’s Horizon 2020 research and innovation program
Zitieren
APA
Pfützner, A., Tencer, B., Stamm, B., Mehta, M., Sharma, P., Gilyazev, R., Jensch, H., Thomé, N., & Huth, M. (2023). Miniaturization of an Osmotic Pressure-Based Glucose Sensor for Continuous Intraperitoneal and Subcutaneous Glucose Monitoring by Means of Nanotechnology. Sensors. https://doi.org/10.3390/s23094541
Vancouver
Pfützner A, Tencer B, Stamm B, Mehta M, Sharma P, Gilyazev R, et al. Miniaturization of an Osmotic Pressure-Based Glucose Sensor for Continuous Intraperitoneal and Subcutaneous Glucose Monitoring by Means of Nanotechnology. Sensors. 2023. doi:10.3390/s23094541
BibTeX
@article{Pftzner2023,
author = {Pfützner, Andreas and Tencer, Barbora and Stamm, Boris and Mehta, Mandar and Sharma, Preeti and Gilyazev, Rustam and Jensch, Hendrick and Thomé, Nicole and Huth, Michael},
title = {Miniaturization of an Osmotic Pressure-Based Glucose Sensor for Continuous Intraperitoneal and Subcutaneous Glucose Monitoring by Means of Nanotechnology},
journal = {Sensors},
year = {2023},
doi = {10.3390/s23094541}
}
EUVIMED